dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Mir Perez, Cristina |
dc.contributor.author | Garcia Mayea, Yoelsis |
dc.contributor.author | García Murias, Laia |
dc.contributor.author | Herrero, Pol |
dc.contributor.author | Canela, Nuria |
dc.contributor.author | Tabernero Gallego, Rocio |
dc.contributor.author | Lorente Guerrero, Juan |
dc.contributor.author | Castellví Vives, Josep |
dc.contributor.author | Lleonart Pajarin, Matilde |
dc.date.accessioned | 2022-05-05T07:29:30Z |
dc.date.available | 2022-05-05T07:29:30Z |
dc.date.issued | 2021-10-01 |
dc.identifier.citation | Mir C, Garcia-Mayea Y, Garcia L, Herrero P, Canela N, Tabernero R, et al. SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation. Cancers. 2021 Oct 1;13(19):4952. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7478 |
dc.description | Cèl·lules mare del càncer; Quimioresistència |
dc.description.sponsorship | This research was supported by grants from the Instituto de Salud Carlos III (ISCIII): PI15/01262 and CP03/00101 (M.E.LL.), PI19/00560 (J.G.-P.), and CIBERONC (M.E.LL. and IDI2018/155 J.P.R.) and was co-financed by the European Regional Fund (ERDF) and AECC (Spanish Association of Cancer Research) Founding Ref. GC16173720CARR (M.E.LL.). Y.G.M. and C.M. were supported by the VHIR and iP-FIS (ISCIII) fellowships, respectively. We acknowledge the Principado de Asturias BioBank (PT17/0015/0023). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13(19) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Coll - Càncer - Tractament |
dc.subject | Cap - Càncer - Tractament |
dc.subject | Resistència als medicaments |
dc.subject.mesh | Head and Neck Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Carcinoma, Squamous Cell |
dc.subject.mesh | Drug Resistance, Neoplasm |
dc.title | SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13194952 |
dc.subject.decs | neoplasias de cabeza y cuello |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | carcinoma de células escamosas |
dc.subject.decs | resistencia a los antineoplásicos |
dc.relation.publishversion | https://doi.org/10.3390/cancers13194952 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Mir C] Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Faculty of Medicine, University of Barcelona, Barcelona, Spain. [Garcia-Mayea Y, Garcia L, Castellvi J] Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Herrero P, Canela N] Eurecat, Centre Tecnològic de Catalunya–Centre for Omic Sciences (COS), Joint Unit Universitat Rovira i Virgili-EURECAT, Reus, Spain. [Tabernero R, Lorente J] Servei d’Otorinolaringologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [LLeonart ME] Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain |
dc.identifier.pmid | 34638436 |
dc.identifier.wos | 000773923000043 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F01262 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |